Intranasal administration of testosterone increased immobile-sniffing, exploratory behavior, motor behavior and grooming behavior in rats

Hormones and Behavior

Volumn 59, Issue 4, 2011, Pages 477-483

  Zhang, Guoliang ^a   Shi, Geming ^a   Tan, Huibing ^b   Kang, Yunxiao ^a   Cui, Huixian ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b WESTERN UNIVERSITY   (Canada)

Author keywords

Behavior; Intranasal administration; Open field; Rats; Testosterone

Indexed keywords

TESTOSTERONE;

ANDROGEN DEFICIENCY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPLORATORY BEHAVIOR; GONADECTOMY; GROOMING; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SNIFFING;

ADMINISTRATION, INTRANASAL; ANALYSIS OF VARIANCE; ANDROGENS; ANIMALS; EXPLORATORY BEHAVIOR; GROOMING; MALE; MOTOR ACTIVITY; ORCHIECTOMY; RATS; RATS, WISTAR; TESTOSTERONE;

EID: 79954686955     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2011.01.007     Document Type: Article

References (49)

1. Adler A., Vescovo P., Robinson J.K., Kritzer M.F. Gonadectomy in adult life increases tyrosine hydroxylase immunoreactivity in the prefrontal cortex and decreases open field activity in male rats. Neuroscience 1999, 89(3):939-954.
2. Banks W.A., Morley J.E., Niehoff M.L., Mattern C. Delivery of testosterone to the brain by intranasal administration: comparison to intravenous testosterone. J. Drug Target. 2009, 17(2):91-97.
3. Casarrubea M., Sorbera F., Crescimanno G. Multivariate analysis of the modifications induced by an environmental acoustic cue on rat exploratory behavior. Physiol. Behav. 2008, 93(4-5):687-696.
4. Casarrubea M., Sorbera F., Crescimanno G. Structure of rat behavior in hole-board: I. Multivariate analysis of response to anxiety. Physiol. Behav. 2009, 96(1):174-179.
5. Casarrubea M., Sorbera F., Crescimanno G. Structure of rat behavior in hole-board: II. Multivariate analysis of modifications induced by diazepam. Physiol. Behav. 2009, 96(4-5):683-692.
6. Costantino H.R., Illum L., Brandt G., Johnson P.H., Quay S.C. Intranasal delivery: physicochemical and therapeutic aspects. Int. J. Pharm. 2007, 337(1-2):1-24.
7. Creutz L.M., Kritzer M.F. Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats. J. Comp. Neurol. 2004, 476(4):348-362.
8. de Souza Silva M.A., Mattern C., Topic B., Buddenberg T.E., Huston J.P. Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone. Eur. Neuropsychopharmacol. 2009, 19(1):53-63.
9. DonCarlos L.L., Monroy E., Morrell J.I. Distribution of estrogen receptor-immunoreactive cells in the forebrain of the female guinea pig. J. Comp. Neurol. 1991, 305(4):591-612.
10. Downer J.B., Jones L.A., Engelbach J.A., Lich L.L., Mao W., Carlson K.E., Katzenellenbogen J.A., Welch M.J. Comparison of animal models for the evaluation of radiolabeled androgens. Nucl. Med. Biol. 2001, 28(6):613-626.
11. Edinger K.L., Frye C.A. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology 2005, 30(5):418-430.
12. Ericson E., Samuelsson J., Ahlenius S. Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations. J. Pharmacol. Methods 1991, 25(2):111-122.
13. Frye C.A., Seliga A.M. Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats. Cogn. Affect. Behav. Neurosci. 2001, 1(4):371-381.
14. Frye C.A., Edinger K., Sumida K. Androgen administration to aged male mice increases anti-anxiety behavior and enhances cognitive performance. Neuropsychopharmacology 2008, 33(5):1049-1061.
15. Gold S.M., Voskuhl R.R. Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders. Curr. Opin. Investig. Drugs 2006, 7(7):625-630.
16. Graff C.L., Pollack G.M. Nasal drug administration: potential for targeted central nervous system delivery. J. Pharm. Sci. 2005, 94(6):1187-1195.
17. Handelsman D.J., Mackey M.A., Howe C., Turner L., Conway A.J. An analysis of testosterone implants for androgen replacement therapy. Clin Endocrinol Oxf. 1997, 47(3):311-316.
18. Hanson L.R., Frey W.H. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008, 10(9 Suppl 3):S5.
19. Hillegaart V., Wadenberg M.L., Ahlenius S. Effects of 8-OH-DPAT on motor activity in the rat. Pharmacol. Biochem. Behav. 1989, 32(3):797-800.
20. Hobbs C.J., Jones R.E., Plymate S.R. The effects of sex hormone binding globulin (SHBG) on testosterone transport into the cerebrospinal fluid. J. Steroid Biochem. Mol. Biol. 1992, 42(6):629-635.
21. Hoberman J.M., Yesalis C.E. The history of synthetic testosterone. Sci. Am. 1995, 272(2):76-81.
22. Hussain A.A., Kimura R., Huang C.H. Nasal absorption of testosterone in rats. J. Pharm. Sci. 1984, 73(9):1300-1301.
23. Illum L. Is nose-to-brain transport of drugs in man a reality?. J. Pharm. Pharmacol. 2004, 56(1):3-17.
24. Illum L. Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?. J. Pharm. Sci. 2007, 96(3):473-483.
25. Jordan W.P. Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems. Am. J. Contact Dermat. 1997, 8(2):108-113.
26. Kalueff A.V., Tuohimaa P. Grooming analysis algorithm for neurobehavioural stress research. Brain Res. Brain Res. Protoc. 2004, 13(3):151-158.
27. Kalueff A.V., Tuohimaa P. The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research. J Neurosci Methods. 2005, 143(2):169-177.
28. Kalueff A.V., Aldridge J.W., LaPorte J.L., Murphy D.L., Tuohimaa P. Analyzing grooming microstructure in neurobehavioral experiments. Nat. Protoc. 2007, 2(10):2538-2544.
29. Kritzer M.F. Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. J. Comp. Neurol. 1997, 379(2):247-260.
30. Lambadjieva N.D. Influence of testosterone on some behavioral reactions of male immature rats exposed to continual light. Meth. Find. Exp. Clin. Pharmacol. 1999, 21(1):17-20.
31. Li J.S., Huang Y.C. Early androgen treatment influences the pattern and amount of locomotion activity differently and sexually differentially in an animal model of ADHD. Behav. Brain Res. 2006, 175(1):176-182.
32. Mattern C., Hoffmann C., Morley J.E., Badiu C. Testosterone supplementation for hypogonadal men by the nasal route. Aging Male 2008, 11(4):171-178.
33. Meyerson B.J., Höglund A.U. Exploratory and socio-sexual behaviour in the male laboratory rat: a methodological approach for the investigation of drug action. Acta Pharmacol Toxicol Copenh. 1981, 48(2):168-180.
34. Minkin D.M., Meyer M.E., van Haaren F. Behavioral effects of long-term administration of an anabolic steroid in intact and castrated male Wistar rats. Pharmacol. Biochem. Behav. 1993, 44(4):959-963.
35. Mitchell E., Thomas D., Burnet R. Testosterone improves motor function in Parkinson's disease. J. Clin. Neurosci. 2006, 13(1):133-136.
36. Morley J.E., Patrick P., Perry H.M. Evaluation of assays available to measure free testosterone. Metabolism 2002, 51(5):554-559.
37. Nieschlag E. Testosterone treatment comes of age: new options for hypogonadal men. Clin Endocrinol Oxf. 2006, 65(3):275-281.
38. Nieschlag E., Behre H.M., Bouchard P., Corrales J.J., Jones T.H., Stalla G.K., Webb S.M., Wu F.C. Testosterone replacement therapy: current trends and future directions. Hum. Reprod. Update 2004, 10(5):409-419.
39. Pardridge W.M., Mietus L.J., Frumar A.M., Davidson B.J., Judd H.L. Effects of human serum on transport of testosterone and estradiol into rat brain. Am. J. Physiol. 1980, 239(1):E103-E108.
40. Parker S., Armitage M. Experience with transdermal testosterone replacement therapy for hypogonadal men. Clin Endocrinol Oxf. 1999, 50(1):57-62.
41. Perry P.J., Kutscher E.C., Lund B.C., Yates W.R., Holman T.L., Demers L. Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. J. Forensic Sci. 2003, 48(3):646-651.
42. Pires A., Fortuna A., Alves G., Falcão A. Intranasal drug delivery: how, why and what for?. J. Pharm. Pharm. Sci. 2009, 12(3):288-311.
43. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463(1-3):3-33.
44. Raynaud J.P. Testosterone deficiency syndrome: treatment and cancer risk. J. Steroid Biochem. Mol. Biol. 2009, 114(1-2):96-105.
45. Rojo A.I., Montero C., Salazar M., Close R.M., Fernández-Ruiz J., Sánchez-González M.A., de Sagarra M.R., Jackson-Lewis V., Cavada C., Cuadrado A. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. Eur. J. Neurosci. 2006, 24(7):1874-1884.
46. Rolf C., Knie U., Lemmnitz G., Nieschlag E. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation. Clin Endocrinol Oxf. 2002, 56(5):637-641.
47. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 1990, 294(1):76-95.
48. Thorne R.G., Pronk G.J., Padmanabhan V., Frey W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004, 127(2):481-496.
49. Wultz B., Sagvolden T., Moser E.I., Moser M.B. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav. Neural Biol. 1990, 53(1):88-102.